Capecitabine and docetaxel in treating the metastatic breast cancer

The result of single medications to metastatic cancer of the breast is not so well, to be able to alleviate the signs and symptoms, improve the standard of existence and prolong the survival time, the primary treatment solution is coupled with chemotherapy. At the moment, docetaxel and capecitabine is high effectiveness in dealing with advanced cancer of the breast drug, they combined medication effect is apparent, is known as the most well-liked treatments. Recent literature reported, combined with two drugs has significant advantages than single one of these, such as with the tumor remission rate, time for you to progression and overall survival. Cancer of the breast is easily the most common malignant tumor in female. Incidence in china shows ascendant trend. Data implies that, 5%-15% of cancer of the breast patients with scientifically identified had distant metastases, in certain underdeveloped areas even as much as 20%-25%, for such patients, chemotherapy may be the primary treatment. Anthracycline chemotherapy drugs in cancer of the breast is chemotherapy based drug, and together with the clinical research and application, recent reviews by docetaxel manufacturer reveal that the combined use of docetaxel and capecitabine is ideal drugs following by anthracycline dealing with cancer of the breast after failure. Both coupled with medicine can enhance the curative effect, but no apparent adverse reaction increase. Docetaxel goes to paclitaxel drug, it's a semi-synthetic. Its mechanism relates to the disposable tubulin binding, promote tubulin polymerization, and inhibition of their depolymerization. The outcomes allow it to be stable, therefore obstructing tumor cell mitosis, inhibition of tumor cell replication, killing tumor cells, to offer the antitumor effect, therefore the current of docetaxel in treating metastatic cancer of the breast is among the best drugs. Capecitabine is pharmaceutical recycleables, approved by Food and drug administration of the class in tumor cell activation, and dental fluorinated pyrimidine, after dental administration could be integrally through intestinal tract mucosa absorption, following the 3 steps unique activation systems, achieve the tumor tissue after it's changed into 5-Fu cells and play toxic effect. Its mechanism of action is incorporated in the S phase from the cell cycle of tumor cells, with highly specific, in comparison with 5-Fu its anticancer effect is enhanced, reducing side-effect. Capecitabine plus docetaxel therapy for cancer of the breast is comparatively good, especially after menopause and also the ER receptor and PR receptor positive patients is much better. For anorexia, nausea, vomiting, might be rehydration, antiemetic therapy elevated transaminases to liver transaminase, such strategy to the neutropenic patients to colony stimulating factor after treatment, could be promptly receiving chemotherapy and may complete the whole span of chemotherapy individual patients developed hands-feet syndrome, stomatitis, phlebitis, allergy, are enhancing after because of the corresponding treatment. To summarize, docetaxel coupled with capecitabine in dealing with metastatic cancer of the breast is capable of good curative effect soon, and also the adverse responses could be tolerated, could be controlled through corresponding techniques, no treatment termination due to apparent adverse responses. The combined application of these two drugs can improve the standard of patients' existence, clinical tumor control rates are good, in conjuction with the goal of dealing with advanced cancer. Source:http://world wide web.cospcn.com